BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36758375)

  • 21. Second primary malignancies after ocular adnexal lymphoma diagnosis.
    Loya A; Ramachandran V; Ayaz T; Weng CY
    BMC Ophthalmol; 2021 Apr; 21(1):162. PubMed ID: 33827494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Second Primary Malignancies in Mucosa-Associated Lymphoid Tissue Lymphomas: A SEER Database Interrogation.
    Timilsina S; Damato A; Budhathoki N; Grossbard ML; Braunstein M
    Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):76-81. PubMed ID: 34493476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Langerhans cell histiocytosis arising after Hodgkin's disease.
    Ferrari A; Fabietti P; Vessecchia G; Laffranchi A; Lombardi L; Massimino M; Fossati-Bellani F; Giardini R
    Pediatr Hematol Oncol; 1997; 14(6):585-8. PubMed ID: 9383812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk and outcome of second primary malignancy in patients with classical Hodgkin lymphoma.
    Wang F
    Medicine (Baltimore); 2022 Dec; 101(48):e31967. PubMed ID: 36482535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
    Bu X; Wang X; Wei L; Liu J; Chen M
    Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004.
    Guyot-Goubin A; Donadieu J; Barkaoui M; Bellec S; Thomas C; Clavel J
    Pediatr Blood Cancer; 2008 Jul; 51(1):71-5. PubMed ID: 18260117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Langerhans cell histiocytosis.
    Grana N
    Cancer Control; 2014 Oct; 21(4):328-34. PubMed ID: 25310214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.
    Minkov M
    Paediatr Drugs; 2011 Apr; 13(2):75-86. PubMed ID: 21351807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethnicity, race, and socioeconomic status influence incidence of Langerhans cell histiocytosis.
    Ribeiro KB; Degar B; Antoneli CB; Rollins B; Rodriguez-Galindo C
    Pediatr Blood Cancer; 2015 Jun; 62(6):982-7. PubMed ID: 25586293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and prognostic characteristics of 95 cases of Langerhans cell histiocytosis in children: a single-institute experience from 2013 to 2020.
    Tang X; Gao J; Ma ZG; Guo X; Li Q; Wan Z; Sun JJ
    Ann Med; 2021 Dec; 53(1):1537-1546. PubMed ID: 34459688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis.
    Minkov M; Pötschger U; Thacker N; Astigarraga I; Braier J; Donadieu J; Henter JI; Lehrnbecher T; Rodriguez-Galindo C; Sieni E; Nanduri V; van den Bos C; Abla O;
    J Pediatr; 2021 Oct; 237():65-70.e3. PubMed ID: 34146548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
    Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
    Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.
    Héritier S; Barkaoui MA; Miron J; Thomas C; Moshous D; Lambilliotte A; Mazingue F; Kebaili K; Jeziorski E; Plat G; Aladjidi N; Pacquement H; Galambrun C; Brugières L; Leverger G; Mansuy L; Paillard C; Deville A; Pagnier A; Lutun A; Gillibert-Yvert M; Stephan JL; Cohen-Aubart F; Haroche J; Pellier I; Millot F; Gandemer V; Martin-Duverneuil N; Taly V; Hélias-Rodzewicz Z; Emile JF; Hoang-Xuan K; Idbaih A; Donadieu J
    Br J Haematol; 2018 Nov; 183(4):608-617. PubMed ID: 30421536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric langerhans cell histiocytosis: single center experience over a 17-year period.
    İnce D; Demirağ B; Özek G; Erbay A; Ortaç R; Oymak Y; Kamer S; Yaman Y; Kundak S; Vergin C
    Turk J Pediatr; 2016; 58(4):349-355. PubMed ID: 28276205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
    Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
    Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis.
    Chellapandian D; Hines MR; Zhang R; Jeng M; van den Bos C; Santa-María López V; Lehmberg K; Sieni E; Wang Y; Nakano T; Williams JA; Fustino NJ; Astigarraga I; Dunkel IJ; Abla O; van Halteren AGS; Pei D; Cheng C; Weitzman S; Sung L; Nichols KE
    Cancer; 2019 Mar; 125(6):963-971. PubMed ID: 30521100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathophysiology and treatment of adult Langerhans cell histiocytosis].
    Tojo A; Kobayashi M
    Rinsho Ketsueki; 2020; 61(9):1028-1034. PubMed ID: 33162496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Langerhans cell histiocytosis of spine: a comparative study of clinical, imaging features, and diagnosis in children, adolescents, and adults.
    Huang WD; Yang XH; Wu ZP; Huang Q; Xiao JR; Yang MS; Zhou ZH; Yan WJ; Song DW; Liu TL; Jia NY
    Spine J; 2013 Sep; 13(9):1108-17. PubMed ID: 23602327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
    Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
    J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histologic patterns of thymic involvement in Langerhans cell proliferations: a clinicopathologic study and review of the literature.
    Picarsic J; Egeler RM; Chikwava K; Patterson K; Jaffe R
    Pediatr Dev Pathol; 2015; 18(2):127-38. PubMed ID: 25629953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.